JP2012526518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526518A5 JP2012526518A5 JP2011533480A JP2011533480A JP2012526518A5 JP 2012526518 A5 JP2012526518 A5 JP 2012526518A5 JP 2011533480 A JP2011533480 A JP 2011533480A JP 2011533480 A JP2011533480 A JP 2011533480A JP 2012526518 A5 JP2012526518 A5 JP 2012526518A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- acid molecule
- humanized antibody
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 13
- 150000007523 nucleic acids Chemical class 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 13
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 8
- 102000036639 antigens Human genes 0.000 claims 8
- 108091007433 antigens Proteins 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 108010024069 integrin alpha9 Proteins 0.000 claims 6
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15888509P | 2009-03-10 | 2009-03-10 | |
| US61/158,885 | 2009-03-10 | ||
| US25107209P | 2009-10-13 | 2009-10-13 | |
| US61/251,072 | 2009-10-13 | ||
| PCT/JP2010/054483 WO2010104208A1 (en) | 2009-03-10 | 2010-03-10 | Generation, expression and characterization of the humanized k33n monoclonal antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526518A JP2012526518A (ja) | 2012-11-01 |
| JP2012526518A5 true JP2012526518A5 (enExample) | 2013-04-18 |
| JP5995442B2 JP5995442B2 (ja) | 2016-09-21 |
Family
ID=42728486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533480A Expired - Fee Related JP5995442B2 (ja) | 2009-03-10 | 2010-03-10 | ヒト化ｋ３３ｎモノクローナル抗体の作製、発現及び解析 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8735552B2 (enExample) |
| EP (1) | EP2406285B1 (enExample) |
| JP (1) | JP5995442B2 (enExample) |
| KR (1) | KR101667227B1 (enExample) |
| CN (1) | CN102333791B (enExample) |
| AU (1) | AU2010221993C1 (enExample) |
| CA (1) | CA2754591C (enExample) |
| WO (1) | WO2010104208A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130309223A1 (en) | 2012-05-18 | 2013-11-21 | Seattle Genetics, Inc. | CD33 Antibodies And Use Of Same To Treat Cancer |
| US9850302B2 (en) * | 2013-07-12 | 2017-12-26 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
| EP3442584B1 (en) | 2016-03-15 | 2021-07-28 | Seagen Inc. | Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors |
| US11110179B2 (en) | 2016-06-03 | 2021-09-07 | Seagen Inc. | Combination of CD33 antibody drug conjugates with chemotherapeutic agents |
| EP3469001A4 (en) | 2016-06-09 | 2020-05-06 | Seattle Genetics, Inc. | COMBINATIONS OF PBD-BASED ANTIBODY CONJUGATES WITH FLT3 INHIBITORS |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5258498A (en) | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| DE768377T1 (de) | 1988-09-02 | 1998-01-02 | Dyax Corp | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| WO1991010737A1 (en) | 1990-01-11 | 1991-07-25 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
| US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| US5314995A (en) | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| WO1992018619A1 (en) | 1991-04-10 | 1992-10-29 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| AU2238292A (en) | 1991-06-14 | 1993-01-12 | Xoma Corporation | Microbially-produced antibody fragments and their conjugates |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| ES2341666T3 (es) | 1991-12-02 | 2010-06-24 | Medimmune Limited | Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos. |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ZA932522B (en) | 1992-04-10 | 1993-12-20 | Res Dev Foundation | Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens |
| WO1994004670A1 (en) | 1992-08-26 | 1994-03-03 | President And Fellows Of Harvard College | Use of the cytokine ip-10 as an anti-tumor agent |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| EP0733070A1 (en) | 1993-12-08 | 1996-09-25 | Genzyme Corporation | Process for generating specific antibodies |
| EP1231268B1 (en) | 1994-01-31 | 2005-07-27 | Trustees Of Boston University | Polyclonal antibody libraries |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| JP2978435B2 (ja) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | アクリロキシプロピルシランの製造方法 |
| ATE412013T1 (de) | 2001-04-05 | 2008-11-15 | Immuno Biological Lab Co Ltd | Anti-osteopontin-antikörper und dessen verwendung |
| US7572640B2 (en) * | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| CN101103044B (zh) * | 2005-01-13 | 2013-01-02 | 株式会社遗传科技 | 抗α9整联蛋白抗体及其用途 |
| HRP20150691T1 (hr) * | 2005-11-18 | 2015-11-06 | Glenmark Pharmaceuticals S.A. | Anti-alfa2 integrin protutijela i njihova uporaba |
| US8221754B2 (en) | 2006-07-12 | 2012-07-17 | Gene Techno Science Co., Ltd. | Antihuman α9 integrin antibody and use of the same |
| CA2711771C (en) * | 2008-01-11 | 2017-01-24 | Gene Techno Science Co., Ltd. | Humanized anti-.alpha.9 integrin antibodies and the uses thereof |
| JP5306659B2 (ja) * | 2008-01-11 | 2013-10-02 | 株式会社ジーンテクノサイエンス | 抗ヒトα９インテグリン抗体とその用途 |
| EP2243829B1 (en) * | 2008-01-11 | 2014-08-20 | Astellas Pharma Inc. | IMPROVED HUMANIZED ANTI-HUMAN alpha9-INTEGRIN ANTIBODY |
| KR101599096B1 (ko) * | 2009-02-23 | 2016-03-02 | 가부시키가이샤 진 테크노 사이언스 | 항인간 α９ 인테그린 항체와 그 용도 |
-
2010
- 2010-03-10 WO PCT/JP2010/054483 patent/WO2010104208A1/en not_active Ceased
- 2010-03-10 EP EP10750953.1A patent/EP2406285B1/en not_active Not-in-force
- 2010-03-10 JP JP2011533480A patent/JP5995442B2/ja not_active Expired - Fee Related
- 2010-03-10 CA CA2754591A patent/CA2754591C/en not_active Expired - Fee Related
- 2010-03-10 CN CN201080009550.XA patent/CN102333791B/zh not_active Expired - Fee Related
- 2010-03-10 AU AU2010221993A patent/AU2010221993C1/en not_active Ceased
- 2010-03-10 US US13/201,847 patent/US8735552B2/en not_active Expired - Fee Related
- 2010-03-10 KR KR1020117022930A patent/KR101667227B1/ko not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012504955A5 (enExample) | ||
| JP2022061992A5 (enExample) | ||
| JP5734988B2 (ja) | Ｒｓｖ特異的結合分子 | |
| JP2011518125A5 (enExample) | ||
| JP2010516229A5 (enExample) | ||
| JP2020500538A5 (enExample) | ||
| JP2013502204A5 (enExample) | ||
| JP2018521638A5 (enExample) | ||
| JP2010528601A5 (enExample) | ||
| IL261585A (en) | Antigen-binding human proteins that bind beta-klotho, fgf receptors and their complexes | |
| JP2011528902A5 (enExample) | ||
| JP2014511179A5 (enExample) | ||
| JP2007097598A5 (enExample) | ||
| JP2012526542A5 (enExample) | ||
| FI3922645T3 (fi) | Pro-/latentin myostatiinin vasta-aineita ja niiden käyttötapoja | |
| JP2008508859A5 (enExample) | ||
| JP2019536806A5 (enExample) | ||
| JP2010524435A5 (enExample) | ||
| RU2016119152A (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| JP2012513214A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| JP2015522252A5 (enExample) | ||
| JP2018521691A5 (enExample) | ||
| JP2012509881A5 (enExample) | ||
| JP2012116856A5 (enExample) |